ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 170983 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 170983; 2) Community: the network communities that were significantly associated with the response to NSC 170983; 3) Molecule: the relationships between components within communities and NSC 170983; 4) MDR: the compounds that were significantly associated with the NSC 170983.

NSC Compound Enrichment Correlation
NSC 684046 Propanedithioamide, 2-[(4-aminocarbonyl-1H-imidazol-5-yl)hydrazono]-N-methyl- 0.0342636096654271 -0.2453353
NSC 689735 Null 0.0342636096654271 -0.10450213
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0342636096654271 -0.078635589
NSC 735408 Null 0.0342636096654271 -0.35709018
NSC 759178 Pipamperone 0.0342636096654271 -0.42309781
NSC 119875 Cisplatin 0.0342636096654276 -0.24799098
NSC 18298 Null 0.0385203205529756 -0.34889339
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0385203205529756 0.30348844
NSC 282159 EN 589 0.0385203205529756 -0.31138989
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0385203205529756 -0.13230613
Total:39  Current:27    [First] [Prev] [Next] [Last]